News

Categories

June 29, 2023

Zymeworks Appoints New Director

June 26, 2023

Zymeworks Set To Join Russell 3000®, Russell 2000®, And Russell Microcap® Indexes

June 2, 2023

Jazz Pharmaceuticals and Zymeworks Present Positive Pivotal Phase 2b Trial Data at ASCO 2023 Evaluating Zanidatamab in HER2-Amplified Biliary Tract Cancers

June 1, 2023

Zymeworks Announces Participation In Upcoming Investor Conferences

May 18, 2023

Zymeworks Announces Departure of Neil Klompas, President and Chief Operating Officer

May 8, 2023

Zymeworks Provides Corporate Update and Reports First Quarter 2023 Financial Results

May 1, 2023

Zymeworks Announces Participation In Upcoming Investor Conferences

April 18, 2023

Zymeworks Presents New Data from Multiple Preclinical and Clinical Development Programs at the 2023 American Association for Cancer Research Annual Meeting

April 17, 2023

Zymeworks To Host First Quarter 2023 Results Conference Call

April 10, 2023

Zymeworks Announces Appointment of Derek J. Miller to its Board of Directors

April 3, 2023

Zymeworks Announces Participation In Upcoming Investor Conferences

March 14, 2023

Zymeworks To Present Updated Data On Multiple Product Candidates At The American Association For Cancer Research (AACR) Annual Meeting